Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses

類似資料

• A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing
  著者:: Saade, Fadi, 等
  出版事項: (2013)
• Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
  著者:: Honda-Okubo, Yoshikazu, 等
  出版事項: (2015)
• Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
  著者:: Gordon, David L., 等
  出版事項: (2016)
• Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
  著者:: Petrovsky, Nikolai, 等
  出版事項: (2015)
• A Single Immunization with Inactivated H1N1 Influenza Vaccine Formulated With Delta Inulin Adjuvant (Advax™) Overcomes Pregnancy-Associated Immune Suppression and Enhances Passive Neonatal Protection
  著者:: Honda-Okubo, Yoshikazu, 等
  出版事項: (2014)